Mette Kirstine Agger - Nov 2, 2023 Form 3 Insider Report for Lexeo Therapeutics, Inc. (LXEO)

Role
Director
Signature
/s/ Jenny Robertson, Attorney-in-Fact
Stock symbol
LXEO
Transactions as of
Nov 2, 2023
Transactions value $
$0
Form type
3
Date filed
11/2/2023, 09:15 PM
Previous filing
Jun 8, 2023
Next filing
Feb 6, 2024

No securities are beneficially owned.

Remarks:

No securities are beneficially owend. Exhibit List - Exhibit 24 - Power of Attorney